Pfizer invests €50m in its production facilities in Lower Austria
• • •
Pharmaceutical company Pfizer is investing €50m in the expansion of its plant in Orth on the Danube in Lower Austria. The new production facilities are due to be opened in 2021.
The company is planning to build modern office buildings and new labs for an international quality control competence centre for vaccines and it is also going to expand its current infrastructure for the production of vaccines, according to a press release. With a capacity of around 12 million vaccine doses per year, the plant in Orth produces a tick-borne encephalitis vaccine and a meningitis C vaccine, which are exported worldwide.
“Pfizer’s investment in its facilities in Orth on the Danube is a significant milestone, which secures highly specialised jobs in the region and strengthens Austria as a location for business and the pharmaceuticals industry,” says Robin Rumler, Managing Director of Pfizer Corporation Austria.
Pfizer currently employs around 520 people in the Vienna Region. In addition to its plant in Lower Austria, it also has a sales office in Vienna.